Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

Zhang, Xin; Cai, Qiyan; Wang, Xiaohui; Liao, Ke; Hu, Changchun; Chen, Hong

Zhang, Xin; Cai, Qiyan; Wang, Xiaohui; Liao, Ke; Hu, Changchun; Chen, Hong.

Afiliação

Zhang X; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Cai Q; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wang X; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liao K; Chongqing Medical University, Chongqing, China.
Hu C; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chen H; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. hopehong2019@126.com.

J Thromb Thrombolysis ; 52(3): 863-871, 2021 Oct.

Article em En | MEDLINE | ID: mdl-33674983

Assuntos

Embolia Pulmonar; Tromboembolia Venosa; Trombose Venosa; Idoso; Idoso de 80 Anos ou mais; Anticoagulantes; Inibidores do Fator Xa/efeitos adversos; Hemorragia/induzido quimicamente; Humanos; Rivaroxabana/efeitos adversos; Tromboembolia Venosa/tratamento farmacológico

Palavras-chave

Deep vein thrombosis; Elderly patients; Pulmonary embolism; Rivaroxaban; Venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Trombose Venosa / Tromboembolia Venosa Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google